Senior insider sale
MINERALYS THERAPEUTICS, INC. — senior position signals high conviction
$689.8K
15K shares
What this filing means
KARYDAS DAPHNE plans to sell 15K shares of MINERALYS THERAPEUTICS, INC. valued at approximately $689.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/13/2025ACC: 0001964306-25-000405
Director
Since Feb 2026
15K
Shares to sell
$689.8K
Approx. market value
15K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Exercise of employee stock options
Broker assisted cashless exercise
11/13/2025
15KTotal acquired15K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/13/2025 | Exercise of employee stock options Broker assisted cashless exercise | 15K | — |
| Total | 15K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
15K
Market value
$689.8K
11/13/2025
Total
Units
15K
Value
$689.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
11/13/2025 | 15K | $689.8K | NASDAQ | Planned |
| Total | 15K | $689.8K | ||